Bionano Genomics (BNGO) Gross Margin (2017 - 2026)
Bionano Genomics (BNGO) posted Gross Margin of 48.63% for Q1 2026, up 13.76% sequentially from 42.75% in Q4 2025, and up 313.0% YoY from 11.78% in Q1 2025.
Bionano Genomics (BNGO) Gross Margin (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Gross Margin for 10 years, with the latest figure at 48.63% in Q1 2026.
- Quarterly Gross Margin rose 313.0% year-over-year to 48.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 46.97% (up 2911.0% YoY) and the FY2025 annual result came in at 46.25%, up 4502.0% from the prior year.
- Gross Margin improved to 48.63% in Q1 2026 per BNGO's latest filing, from 42.75% in the prior quarter.
- Over five years, Gross Margin peaked at 98.08% in Q4 2024 and troughed at 139.07% in Q3 2024.
- A 5-year average of 26.46% and a median of 29.5% in 2023 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2024 and 2025: Gross Margin sank 16858 bps in 2024, then soared 18482 bps in 2025.
- Over 5 years, Gross Margin stood at 21.97% in 2022, then grew by 3 bps to 22.74% in 2023, then surged by 331 bps to 98.08% in 2024, then tumbled by 56 bps to 42.75% in 2025, then grew by 14 bps to 48.63% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 48.63%, 42.75%, and 45.74% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.78% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 46.46% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 59.33% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 58.84% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 28.82% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 37.74% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 58.22% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 68.00% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 34.86% |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | 52.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.80% |
| Mar 31, 2026 | 48.63% |
| Dec 31, 2025 | 42.75% |
| Sep 30, 2025 | 45.74% |
| Jun 30, 2025 | 51.64% |
| Mar 31, 2025 | 45.50% |
| Dec 31, 2024 | 98.08% |
| Sep 30, 2024 | -139.07% |
| Jun 30, 2024 | 33.26% |
| Mar 31, 2024 | 32.20% |
| Dec 31, 2023 | 22.74% |
| Sep 30, 2023 | 29.50% |
| Jun 30, 2023 | 26.65% |
| Mar 31, 2023 | 27.92% |
| Dec 31, 2022 | 21.97% |
| Sep 30, 2022 | 25.05% |
| Jun 30, 2022 | 22.05% |
| Mar 31, 2022 | 15.12% |
| Dec 31, 2021 | 3.79% |
| Sep 30, 2021 | 24.79% |